Perbedaan Nusa Konstruksi Enjiniring Tbk dan Brigit Biofarmaka Teknologi Tbk.: Nusa Konstruksi Enjiniring Tbk diperdagangkan di Rp131 (kapitalisasi pasar 742,52 M, volume 24 jam 2,02 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp246 (kapitalisasi pasar 167,37 M, volume 24 jam 71 rb). Perbedaan utamanya: Nusa Konstruksi Enjiniring Tbk jauh lebih besar — sekitar 4,4× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Nusa Konstruksi Enjiniring Tbk lebih aktif diperdagangkan (2,02 jt vs 71 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGIK | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 742,52 M | 167,37 M |
Volume | 2,02 jt | 71 rb |
Lot | 20,21 rb | 710 |
Perputaran | 266,34 jt | 17,51 jt |
Harga Rata-rata | 131,77 | 246,63 |
Nilai Transaksi | 266,34 jt | 17,51 jt |
Harga Ekuilibrium Indikatif | 131 | 246 |
Volume Ekuilibrium Indikatif | 119 | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Nusa Konstruksi Enjiniring Tbk formerly PT Duta Graha Indah Tbk (the company) was established on 11 Jan 1982 based on Notaries Deed No.38. The Company’s articles of association has been amended several times, most recently by notarial deed No. 21 of Mr. Haryanto, S.H., dated Sep 18, 2007, concerning among others, increase Company’s authorized stock, paid up capital and public offering of stock.
Selengkapnya di halaman DGIK →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →